Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Literature
1.
Korobelnik JF, Kodjikian L, Delcourt C, Gualino V, Leaback R, Pinchinat S, Velard ME (2016) Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France. Graefes Arch Clin Exp Ophthalmol. doi:10.​1007/​s00417-016-3394-y PubMedPubMedCentral
2.
Freund KB, Korobelnik JF, Deveny R et al (2015) Treat-and extend regimens with anti-VEGF agents in retinal diseases. Retina 35:1489–1506CrossRefPubMed
3.
Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS (2006) Normal macular thickness measurements in healthy eyes using stratus optical coherence tomography. Arch Ophthalmol 124:193–198CrossRefPubMedPubMedCentral
4.
Gover S, Murthy RK, Brar VS, Chalam KV (2009) Normative data formacular thickness by high-definition spectral-domain optical coherence tomography (spectralis). Am J Ophthalmol 148:266–271CrossRef
5.
Kuppermann BD, Haller JA, Bandello F (2014) Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion. Retina 34:1743–1749CrossRefPubMed
6.
Coscas G, Augustin A, Bandello F et al (2014) Retreatment with ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 24:1–9CrossRefPubMed
7.
Călugăru D, Călugăru M (2015) Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year 2results of a prospective clinical study. J Ocul Pharmacol Ther 31:78–86CrossRefPubMed
8.
Călugăru D, Călugăru M (2016) Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study. Acta Ophthalmol 94:80–81
9.
Călugăru D, Călugăru M (2015) Therapies for macular edema associated with central retinal vein occlusions. Ophthalmology 122:65–66CrossRef
10.
Călugăru D, Călugăru M (2016) Pro-permeability factors after dexamethasone implant in retinal vein occlusion: the ozurdex for retinal vein occlusion (ORVO) study. Am J Ophthalmol 161:215–216CrossRefPubMed
Metadata
Title
Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
Authors
Dan Călugăru
Mihai Călugăru
Publication date
01-01-2017
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 1/2017
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-016-3512-x

Other articles of this Issue 1/2017

Graefe's Archive for Clinical and Experimental Ophthalmology 1/2017 Go to the issue

Basic Science

Arginase activity, urea, and hydroxyproline concentration are reduced in keratoconus keratocytes

Neurophthalmology

Effect of uncorrection versus full correction on myopia progression in 12-year-old children

Letter to the Editor (by invitation)

Descemet stripping automated endothelial keratoplasty using corneas from elderly donors

Cornea

Serial optical coherence tomography angiography for corneal vascularization

Retinal Disorders

Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial

Basic Science

FK962 induces neurite outgrowth in cultured monkey trigeminal ganglion cells